Research advances in targeted therapy of lupus nephritis
As the most common secondary glomerulonephritis in China, lupus nephritis (LN) is one of the most severe consequences of systemic lupus erythematosus (SLE). Currently the sole option of treating LN clinically is with hormones plus immunosuppressants for managing symptoms and arresting the loss of re...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Nephrology
2024-04-01
|
| Series: | Linchuang shenzangbing zazhi |
| Subjects: | |
| Online Access: | http://www.lcszb.com/cn/article/doi/10.3969/j.issn.1671-2390.2024.04.009 |